Spots Global Cancer Trial Database for Real World Evidence on the Use of Medical Cannabis in Pediatrics
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real World Evidence on the Use of Medical Cannabis in Pediatrics
Official Title: Real World Evidence on the Use of Medical Cannabis in Pediatrics: A Prospective Observational Study
Study ID: NCT05863910
Interventions
Study Description
Brief Summary: CAN-RWE is an observational study that is following 500 children who have authorizations for medical cannabis for two years from across Canada.
Detailed Description: Pediatric patients (3 to 17 years) using medical cannabis (MC) for pain, sleep, mood, behaviour, seizures, treatment of cancer, or to manage symptoms related to cancer or cancer-treatment are eligible to join this 24-month study if they have a valid MC authorization. Following screening, eligible participants will be contacted by the study coordinator. Following informed consent, study participants will record complete outcome measures on pain, sleep, mood (anxiety, depression and positive affect), behaviour, as well as report their cannabis use and indication-specific outcomes as applicable at 3, 6, 12, and 18 weeks, as well as 6, 12, 18 and 24-months.
Keywords
Eligibility
Minimum Age: 3 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
U Manitoba, Winnipeg, Manitoba, Canada
Contact Details
Name: Sapna Oberoi, MD
Affiliation: University of Manitoba
Role: PRINCIPAL_INVESTIGATOR
Name: Taylor Lougheed, MD
Affiliation: Northern Ontario School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Evan Lewis, MD
Affiliation: Neurology Centre of Toronto
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
